Ali Nabavizadeh, MD
Associate Professor of Radiology at the Hospital of the University of Pennsylvania
Active Radiologist, Penn Presbyterian Medical Center
Active Radiologist , Chester County Hospital
Active Radiologist , Pennsylvania Hospital
Attending Radiologist, Hospital of the University of Pennsylvania
Department: Radiology
Contact information
Hospital of the University of Pennsylvania
Department of Radiology
3400 Spruce Street
Philadelphia, PA 19104
Department of Radiology
3400 Spruce Street
Philadelphia, PA 19104
Publications
Education:
MD (School of Medicine)
Shiraz Medical School, 2002.
Permanent linkMD (School of Medicine)
Shiraz Medical School, 2002.
Description of Clinical Expertise
Dr. Nabavizadeh is primarily an adult neuroradiologist with additional training in pediatric neuroradiology and nuclear radiology. He specializes in using neuroimaging to diagnose various diseases of the central nervous system.Description of Research Expertise
Dr. Nabavizadeh is an Associate Professor of Radiology at the Hospital of the University of Pennsylvania with a research appointment at the Children’s Hospital of Philadelphia and the imaging lead of two consortia, CBTN (The Children’s Brain Tumor Network) dedicated to biospecimen-driven data generation. Dr. Nabavizadeh’s research focuses on multimodality imaging using structural and physiologic MRI imaging with additional PET probes and molecular imaging techniques to better understand the complex nature of brain tumor microenvironment. Dr. Nabavizadeh is the associate editor for the brain tumor section at the American Journal of Neuroradiology and has more than 140 peer-reviewed publications in prestigious journals such as Nature Medicine, Nature Communications, JAMA Neurology, Clinical Cancer Research, Neuro-Oncology, Radiology, and Journal of Nuclear Medicine. He has served as the principal investigator of multiple prospective imaging trials including investigator-initiated trials and industry-sponsored FDA registry trials.Selected Publications
Maoz SL, Lee M, Fischer JL, Choby G, Hwang PH, Wang EW, Kuan EC, Adappa ND, Geltzeiler M, Getz AE, Humphreys IM, Le CH, Pinheiro-Neto CD, Chan EP, Roozdar P, Abuzeid WM, Chang EH, Jafari A, Kingdom TT, Kohanski MA, Lee JK, Lazor JW, Nabavizadeh A, Nayak JV, Palmer JN, Patel ZM, Resnick AC, Smith TL, Snyderman CH, St. John MA, Storm PB, Suh JD, Wang MB, Sim MS, Beswick DM.: Minimal Clinically Important Difference of the Sinonasal Outcome Test in Sinonasal Malignancy. Annals of Otology, Rhinology & Laryngology. Page: 34894261428393, March 2026 Notes: doi: 10.1177/00034894261428393. Epub ahead of print.Li EJ, Kraya A, Costa-Pinheiro P, Scheuermann J, Young AJ, Schubert E, Aboian M, Doot R, Ware JB, Pantel AR, Binder ZA, Storm PB, Resnick AC, Amankulor NM, O'Rourke DM, Desai A, Nasrallah MP, Brem S, Bagley SJ, Mankoff D, Nabavizadeh A: Metabolic imaging and molecular signatures reveal metabolic phenotypes in recurrent glioblastoma Journal of Nuclear Medicine Page: jnumed.125.271476, March 2026 Notes: doi: 10.2967/jnumed.125.271476. Epub ahead of prin.
Tak D, Garomsa BA, Chaunzwa TL, Zapaishchykova A, Climent Pardo JC, Ye Z, Zielke J, Ravipati Y, Vajapeyam S, Mahootiha M, Smith C, Familiar AM, Liu KX, Prabhu S, Bandopadhayay P, Nabavizadeh A, Mueller S, Aerts HJ, Huang RY, Poussaint TY, Kann BH.: A generalizable foundation model for analysis of human brain MRI. Nature Neuroscience Feb 2026 Notes: doi: 10.1038/s41593-026-02202-6. Epub ahead of print.
Kotecha R, Chiang V, Tom MC, Parent E, Nabavizadeh A, Zane E, Peddi S, Sulman EP, Siegel BA, Huang J, Brem S, Ware M, Kesari S, Pope W, Holmes R, Chau A, Teoh EJ, Chao ST, Aboian M: 18F-Fluciclovine Positron Emission Tomography for Detection of Recurrent Brain Metastases after Radiotherapy: Image Interpretation Criteria, Diagnostic Performance, and Safety from the Phase 2b PURSUE Study. International Journal of Radiation Oncology, Biology, Physics Page: S0360-3016(26)00431-1, Feb 2026 Notes: doi: 10.1016/j.ijrobp.2026.02.239. Epub ahead of print.
Chrysochoou D, Gandhi DB, Adib S, Familiar AM, Vunnava B, Varshochi S, Khalili N, Khalili N, Ware JB, Tu W, Jain P, Anderson H, Haldar S, Storm PB, Franson A, Prados M, Kline C, Mueller S, Resnick A, Vossough A, Davatzikos C, Nabavizadeh A, Kazerooni AF.: AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors. NPJ Precis Oncol 10(1): 63, Jan 2026 Notes: doi: 10.1038/s41698-025-01269-x.
Ivanidze J, Vu KV, Fu R, Brandmaier A, Szidonya L, Choudhary G, Starkey J, Wang TJ, Sisti M, McKhann LG, Puri S, Konner M, Roytman M, Lin E, Kuhn A, Osborne JR, Stieg PE, Beal K, Ramakrishna RR, Singh G, Lignelli-Dipple A, Doubrovin M, Vo AH, Welch M, Iwamoto F, Haggiagi A, Donovan L, Diaz M, Gill B, Liechty B, Pisapia DJ, Walker J, Magge RS, Wood M, Corzo VM, Sanusi OR, Raslan A, Dogan A, Bowden S, Nehmeh SA, Nickerson J, Mallak N, Ruiz A, Ambady P, Nabavizadeh A, Barajas RF Jr.: Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma. AJNR Am J Neuroradiol Page: ajnr.A9120, Dec 2025 Notes: doi: 10.3174/ajnr.A9120. Epub ahead of print.
Jung G, Liang Z, Jain P, Deutsch HM, Li F, Rathi KS, Sun Z, Chen X, Straka J, Kazerooni AF, Sun Y, Koptyra MP, Sanchez-Maldonado S, Familiar A, Waanders AJ, Nabavizadeh A, Huang X, Resnick AC, Song Y.: Role of repulsive guidance signaling and GPR180 in pediatric low-grade glioma infiltration. NPJ Precis Oncol 9(1): 344, Nov 2025.
Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S.: Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNOC005. Clin Cancer Res 31(16): 3463-3475, Aug 2025 Notes: doi: 10.1158/1078-0432.CCR-24-3721.
Bagley SJ, Desai AS, Fraietta JA, Silverbush D, Chafamo D, Freeburg NF, Gopikrishna GK, Rech AJ, Nabavizadeh A, Bagley LJ, Park J, Jarocha D, Martins R, Sarmiento N, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz RM, Jadlowsky JK, Mackey S, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Barrett D, Colbourn R, Nasrallah MP, Mourelatos Z, Hwang WT, Alanio C, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM.: Intracerebroventricular bivalent CAR T cells targeting EGFR epitope 806 and IL-13Rα2 in recurrent glioblastoma: a phase 1 dose finding study. Nature Medicine 31(8): 2778-2787, Aug 2025 Notes: doi: 10.1038/s41591-025-03745-0. Epub 2025 Jun 1.
Climent Pardo JC, Zapaishchykova A, Boyd A, Tak D, Zielke J, Mahootiha M, Ye Z, Vajapeyam S, Jones J, Smith C, Familiar AM, Nabavizadeh A, Bandopadhayay P, Mueller S, Aerts HJWL, Haas-Kogan DA, Michor F, Ligon KL, Poussaint TY, Faghihroohi S, Kann BH.: Deep learning volumetrics reveal distinct clinical trajectories for pediatric low-grade gliomas under surveillance: A multicenter study. Neurooncol Adv 7(1): vdaf145, Jul 2025 Notes: doi: 10.1093/noajnl/vdaf145.